Despite the rising competition in the obesity space, we believe that there is room for smaller biotechs like Viking Therapeutics to grab a share of this booming market.

The U.S. surgeon general has urged updating the label on alcoholic drinks to cite the increased risk of cancer.

The drug and biotech industry had a tough time in the past couple of months after Trump announced the appointment of Robert F ...

Stocks were solidly higher in mid-afternoon trading Friday, led by a rally in shares of large-cap technology companies, as ...

As a lifelong bicyclist, I’ve logged tens of thousands of miles commuting in urban areas, pedaling to and from work, enjoying ...

Elvis Presley released the song Stay Away in February of 1968 as part of the soundtrack for the movie Stay Away, Joe. This ...

The US Surgeon General released a report directly linking alcohol to cancer. A BI analysis of alcohol spending shows how ...

Although bipartisan legislation to provide Medicare coverage for obesity treatments has circulated in Congress for more than ...

Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing ...

Axios Visuals The number of prescriptions for GLP-1 drugs jumped roughly 10% in 2024, according to insurance claims data provided to Axios by health analytics company PurpleLab. Why it matters: The ...

Nov. 26, 2024 — Tirzepatide, a new injectable weight-loss drug, reduced the risk of diabetes in patients with obesity and prediabetes by more than 90% over a three-year period, compared with ...

Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality ...